ArticleMolecular therapy oncolytics2022

TTN-AS1 accelerates the growth and migration of nasopharyngeal carcinoma cells via targeting miR-876-5p/NETO2.

Xinping Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.